Matthew P. Coghlan

Granta Park
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Glycemic and bodyweight effects of GIPR coding variation reflect differences in surface expression and intrinsic functional impairment.

Glycemic and bodyweight effects of GIPR coding variation reflect differences in surface expression and intrinsic functional impairment.

Journal: Science advances

Published: September 04, 2026

GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models.

GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian models.

Journal: Diabetes, obesity & metabolism

Published: September 29, 2025

The Sound of Safety: DIVOT (Doppler Imaging for Vascular Orientation in Thoracic Procedures) Protocol.

The Sound of Safety: DIVOT (Doppler Imaging for Vascular Orientation in Thoracic Procedures) Protocol.

Journal: POCUS journal

Published: May 09, 2025

Data-driven prioritization of high-risk individuals for weight loss interventions.

Data-driven prioritization of high-risk individuals for weight loss interventions.

Journal: Nature medicine

Published: April 04, 2025

Glucose-dependent insulinotropic polypeptide (GIP).

Glucose-dependent insulinotropic polypeptide (GIP).

Journal: Molecular metabolism

Published: December 06, 2024

Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.

Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.

Journal: Nature medicine

Published: November 10, 2024

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.

The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice.

Journal: Cell metabolism

Published: March 04, 2024

Structural determinants of dual incretin receptor agonism by tirzepatide.

Structural determinants of dual incretin receptor agonism by tirzepatide.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 25, 2022

Decreasing delirium through music listening (DDM) in critically ill, mechanically ventilated older adults in the intensive care unit: a two-arm, parallel-group, randomized clinical trial.

Decreasing delirium through music listening (DDM) in critically ill, mechanically ventilated older adults in the intensive care unit: a two-arm, parallel-group, randomized clinical trial.

Journal: Trials

Published: March 17, 2022

Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region.

Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the GIPR Region.

Journal: Diabetes

Published: February 15, 2021

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.

GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice.

Journal: The Journal of clinical investigation

Published: November 24, 2020

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: November 12, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026